早期确认性检测与低危前列腺癌主动监测采纳的关联
OBJECTIVE: To examine the relationship between the use and results of early confirmatory testing and persistence on active surveillance (AS).…
要点
- 有利风险前列腺癌患者中32.7%在诊断后6个月内接受早期确认性检测。
- 早期检测结果令人安心者继续主动监测的比例为82%,显著高于其他组。
- 即使结果不令人安心,仍有52%患者继续主动监测,体现决策复杂性。
核心结论
- 早期确认性检测结果令人安心的有利风险前列腺癌患者中主动监测率更高,支持这些检测的临床实用性。
研究设计与样本
- 回顾性队列研究,基于密歇根泌尿外科手术改进协作组注册数据,纳入2016年6月至2017年6月诊断为有利风险前列腺癌的2529例男性。
主要发现
- 2529例患者中32.7%在诊断后6个月内接受早期确认性检测。
- 分子分类器使用最频繁(55%),其次为磁共振成像(34%)和重复活检(11%)。
临床怎么用
- 对有利风险前列腺癌患者,可考虑在诊断后6个月内进行早期确认性检测以支持主动监测决策。
- 早期确认性检测结果令人安心时可增强患者继续主动监测的信心。
- 即使检测结果不令人安心,仍需结合患者意愿进行共享决策,因超过半数患者仍选择主动监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the relationship between the use and results of early confirmatory testing and persistence on active surveillance (AS). METHODS: We identified all men in the Michigan Urological Surgery Improvement Collaborative registry diagnosed with favorable-risk prostate cancer from June 2016 to June 2017. We next examined trends in the use of early confirmatory test(s), defined as repeat biopsy, prostate magnetic resonance imaging, or molecular classifiers obtained within 6 months of the initial cancer diagnosis, in patients with favorable-risk prostate cancer. We then compared the proportion of men remaining on AS 6 months after diagnosis according to reassuring vs nonreassuring results, also stratifying by age and Gleason score. RESULTS: Among 2529 patients, 32.7% underwent early confirmatory testing within 6 months of diagnosis. Its use increased from 25.4% in the second quarter of 2016 to 34.9% in the second quarter of 2017 (P = .025). Molecular classifiers were most frequently used (55%), followed by magnetic resonance imaging (34%) and repeat biopsy (11%). Sixty-four percent (n = 523) had a reassuring result. Rates of AS were higher for patients with early reassuring results; 82% remained on AS (n = 427) compared to 52% (n = 157) of those with nonreassuring results and 51% (n = 873) with no early confirmatory testing (P <.001). CONCLUSION: Rates of AS are higher among men with early reassuring results, supporting the clinical utility of these tests. Nonetheless, high rates of AS among patients with nonreassuring results underscore the complexity of shared decision-making in this setting.
引用
- Kaye DR, Qi J, Morgan TM, et al. Association Between Early Confirmatory Testing and the Adoption of Active Surveillance for Men With Favorable-risk Prostate Cancer. Urology. 2018. PMID: 29792972. doi:10.1016/j.urology.2018.04.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。